Abbott Laboratories (ABT)
ABT Price and Sentiment
ABT Latest news
Buy now to take advantage of what will likely be higher yields to come.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Abbott and the American Diabetes Association® Launch First-of-Its-Kind Community Initiative in Columbus, Ohio, to Advance Access to Diabetes Care and Technology2021-11-09 09:00
ABBOTT PARK, Ill. and ARLINGTON, Va.
Earnings reports for S&P 500 stocks have been exceptionally good so far. Here are 10 stocks to buy that have delivered in Q3.
The Vanguard Health Care Fund (Trades, Portfolio) recently released its portfolio updates for the third quarter of 2021, which ended on Sept. 30.
Dividend stocks could be worth paying attention to as the Federal Reserve may look to pull back its monetary support.
Abbott Launches New Initiative to Drive Diversity in Medical Research and Improve Care Among Under-Represented Populations2021-11-03 09:00
ABBOTT PARK, Ill., Nov. 3, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) today announced the launch of a new initiative designed to help create a more inclusive clinical trial ecosystem through new approaches to training, education, and improving the clinical research infrastructure within the U.S. This effort builds on Abbott's commitment of engaging populations who have historically been under-represented in medical research and will improve health by increasing access to innovative treatment options available within the trials process and increasing insights around how different groups respond to new therapies.
Amid concerns surrounding growing COVID-19 cases affecting the medical products companies' legacy business, we are optimistic about IDXX, HSIC, CGC and PODD's results this time around.
Abbott (ABT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.